In this regard, it has been reported that adaptive NK cells induced by different cytokines (IL-12, IL-15, IL-18) display both in vitro and in vivo enhanced functionality and persistence against ovarian cancer. This evidence concerns the gene IL15 and ovarian carcinoma.